This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Review paper

Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS

Volume: 46, Issue: 8, Pages: 1563 - 1566
Published: Jun 25, 2020
Abstract
Hospitals worldwide are experiencing a shortage in essential intravenous sedative medications. This is attributable to high number and high sedative needs of COVID-19 critical care patients with disruption of drug supply chains. Inhaled volatile anesthetic agents are an abundant resource and readily implementable solution for providing ICU sedation. Inhaled volatile agents may also provide important pulmonary benefits for COVID-19 patients with...
Paper Details
Title
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS
Published Date
Jun 25, 2020
Volume
46
Issue
8
Pages
1563 - 1566
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.